289 filings
Page 3 of 15
6-K
mz6zyj vy
8 Nov 22
Notice of Annual General Meeting of Shareholders
7:02am
6-K
3mhlg
7 Nov 22
Kamada Provides Update on Recent Progress Achieved in Ongoing Pivotal Phase 3 Clinical Trial of Inhaled AAT
7:00am
6-K
b4u yw0r8yor8y9d
26 Oct 22
Kamada to Present at the Credit Suisse 31st Annual Healthcare Conference
7:00am
6-K
f5d bksbx
19 Oct 22
Kamada Awarded $22 Million Extension of Canadian Supply Tender
7:00am
6-K
wzs 1yp2z571r55
17 Aug 22
Report of Foreign Private Issuer
7:00am
6-K
mfeym
10 Aug 22
Report of Foreign Private Issuer
12:00am
6-K
ncvtrvpv awtja
15 Jul 22
Kamada Announces Resolution the Labor Strike at the Company’s Manufacturing Facility in Israel; A New, Eight-Year Collective Agreement Signed
7:04am
6-K
wg6x8r
6 Jul 22
Kamada Announces $11.4 Million International VARIZIG® Procurement Agreement
6:01am
6-K
tllqxmiu
15 Jun 22
Report of Foreign Private Issuer
7:00am
6-K
fuy4ku0
1 Jun 22
Kamada to Host a Virtual Analysts and Investors Meeting to Review its Growth Catalysts
7:02am
6-K
faqlj4
17 May 22
Reiterates Revenue and Profitability Guidance with Significant Growth Expected in 2022
7:05am
6-K
gq8qy4i618sgsp
17 May 22
Report of Foreign Private Issuer
7:00am
6-K
bpgf1mhnby wr
11 May 22
Report of Foreign Private Issuer
7:00am
6-K
gf08ubs4c jp
26 Apr 22
Report of Foreign Private Issuer
8:15am
6-K
ryu09zzp9g5y7
15 Mar 22
Kamada Issues 2022 CEO Letter to Shareholders
7:11am
6-K
f7rkiu2qfa47v
15 Mar 22
Report of Foreign Private Issuer
7:08am
6-K
4ldxis
15 Mar 22
Provides Revenue and Profitability Guidance with Significant Growth Expected in 2022
7:02am
6-K
w3axt75sz7gl1f053
14 Mar 22
Kamada Expands U.S. Leadership Team with Two Key Appointments
7:01am
6-K
xah93yuns6 uh1c7
3 Mar 22
Report of Foreign Private Issuer
7:41am
6-K
cji0nbz1x1r f6q
2 Mar 22
Report of Foreign Private Issuer
7:01am